These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21343793)

  • 41. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prenatal exposure to metamphetamine «shabu»].
    Manzano Varo C; López-Vílchez MÁ; Román Eyo L; García García J; Mur Sierra A
    An Pediatr (Barc); 2017 Feb; 86(2):96-97. PubMed ID: 27346796
    [No Abstract]   [Full Text] [Related]  

  • 43. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand.
    Chomchai C; Na Manorom N; Watanarungsan P; Yossuck P; Chomchai S
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):228-31. PubMed ID: 15272773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.
    Sankaran D; Lakshminrusimha S; Manja V
    J Perinatol; 2022 Mar; 42(3):293-299. PubMed ID: 34785765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-induced bilateral ischemic infarction in an amphetamine addict.
    Christensen MR; Lesnikova I; Madsen LB; Rosendal I; Banner J
    Forensic Sci Med Pathol; 2013 Sep; 9(3):458-61. PubMed ID: 23504704
    [No Abstract]   [Full Text] [Related]  

  • 49. Neurologic manifestations of chronic methamphetamine abuse.
    Rusyniak DE
    Neurol Clin; 2011 Aug; 29(3):641-55. PubMed ID: 21803215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.
    Smith LM; Diaz S; LaGasse LL; Wouldes T; Derauf C; Newman E; Arria A; Huestis MA; Haning W; Strauss A; Della Grotta S; Dansereau LM; Neal C; Lester BM
    Neurotoxicol Teratol; 2015; 51():35-44. PubMed ID: 26212684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].
    Arnaud N; Thomasius R
    Nervenarzt; 2017 Sep; 88(9):1079-1090. PubMed ID: 28721538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Stimulants related mental disorders].
    Iyo M; Sekine Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):507-12. PubMed ID: 14626172
    [No Abstract]   [Full Text] [Related]  

  • 55. Methamphetamine use and dental disease: results of a pilot study.
    Cretzmeyer M; Walker J; Hall JA; Arndt S
    J Dent Child (Chic); 2007; 74(2):85-92. PubMed ID: 18477425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of Methamphetamine «Shabu» in Biological Matrices to Detect Prenatal Exposure: A Case Report and a Literature Review.
    Jarque P; Roca A; Gomila I; Noce V; Barcelo B; Klein J
    Curr Pharm Biotechnol; 2018; 19(2):163-174. PubMed ID: 29701148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 58. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 59. The burden and management of crystal meth use.
    Buxton JA; Dove NA
    CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899
    [No Abstract]   [Full Text] [Related]  

  • 60. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.